Erschienen in:
02.09.2022 | Hospital-Based Dermatology (L Guggina and C Nguyen, Section Editors)
Pemphigus for the Inpatient Dermatologist
verfasst von:
Connor Cole, Kyle Amber
Erschienen in:
Current Dermatology Reports
|
Ausgabe 4/2022
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
Although detailed guidelines exist for the general treatment of pemphigus, reviews specific to inpatient management are sparse. This paper will seek to provide a comprehensive and centralized guide for the treatment of this disease by the inpatient dermatologist.
Recent Findings
Important recent findings include the demonstrated efficacy of rituximab as a first-line agent in pemphigus and its approval by the FDA for the treatment of moderate-to-severe pemphigus in adults in 2018.
Summary
Optimal care for pemphigus in the hospital requires a multi-disciplinary approach, which factors in specific qualities of each patient to develop the proper medication regimen and treatment plan. In addition, proper wound and oral care, diet, and prophylaxis against potential complications are all crucial to timely and appropriate discharge.